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Introduction {#sec005}
============

Patients with epiphora caused by lacrimal passage obstruction often complain of vision-related symptoms. Although the decrease in visual function is rarely detected by conventional visual acuity measurements, several studies have assessed and revealed the negative effects of epiphora on the patient's quality of vision (QoV) and optical quality. QoV is assessed by measuring functional visual acuity (FVA), which demonstrates the change in visual acuity (VA) over time \[[@pone.0233295.ref001],[@pone.0233295.ref002]\]. Patients with lacrimal passage obstruction experience significant deterioration in FVA, and an increase in higher-order aberrations until they undergo lacrimal passage intubation \[[@pone.0233295.ref003]\]. The vision-related quality of life is also significantly impaired before silicone tube intubation for lacrimal passage obstruction, composite score from the 25-item national eye institute visual function questionnaire (NEIVFQ-25) improved 76.3 ± 11.5 to 82.0 ± 11.3 (p = 0.001) after silicone tube intubation \[[@pone.0233295.ref004]\].

Contrast sensitivity, which is the ability to detect differences in luminance between adjacent areas, is a fundamental feature of vision. The measurement of contrast sensitivity provides useful information about QoV that may not be obtained by standard VA testing \[[@pone.0233295.ref005]--[@pone.0233295.ref009]\]. Contrast sensitivity is reduced in epiphora induced by conjunctivochalasis \[[@pone.0233295.ref010]\] or instillation of a gel-forming solution or particle suspension \[[@pone.0233295.ref011]\]. As a result, we hypothesize that contrast sensitivity will also be reduced in eyes with epiphora due to lacrimal passage obstruction. Thus, we aimed to assess contrast sensitivity as a measure of QoV, using different methods in adult eyes with lacrimal passage obstruction.

Materials and methods {#sec006}
=====================

This study was a single institutional prospective case series, approved by the institutional review board of the University of Tsukuba Hospital (H27-153), and adhered to the tenets of the Declaration of Helsinki. The nature and possible consequences of the study were explained in detail, following which all patients provided informed consent.

Patient population {#sec007}
------------------

Patients with unilateral lacrimal passage obstruction who visited the University of Tsukuba Hospital between November 2015 to July 2019 and had a best-corrected distance VA of 20/20 or better in both eyes measured by Snellen testing were considered for enrollment. The inclusion criteria were symptoms of epiphora, and the presence of at least one of the following dacryoendoscopic findings: nasolacrimal duct obstruction, canalicular obstruction, or punctual obstruction. The exclusion criteria were congenital lacrimal duct obstruction, acute dacryocystitis, and a history of ocular surface surgery. Patients with cortical cataract formation in the central lens, unilateral intraocular lens implantation, anisocoria, other ocular diseases, or a history of treatment that might affect contrast sensitivity were also excluded. Patients receiving ophthalmic solution stopped using ophthalmic solution 4 weeks before examinations. A total of 57 patients (men: 17, women: 40; mean age: 60.0 ± 11.4 years) with unilateral lacrimal passage obstruction participated in our study. [Table 1](#pone.0233295.t001){ref-type="table"} presents the classification of the types of obstruction diagnosed in all the participants. The patients presented with epiphora for a median duration of 9 (range 2--82, interquartile range 3--20.5) months.

10.1371/journal.pone.0233295.t001

###### Type of obstruction based on dacryoendoscopy.

![](pone.0233295.t001){#pone.0233295.t001g}

  Underlying Disease                                                                    Cases (*N*)
  ------------------------------------------------------------------------------------- -------------
  Nasolacrimal duct obstruction                                                         34
  Common canalicular obstruction combined with nasolacrimal duct obstruction            14
  Common canalicular obstruction                                                        5
  Upper and lower punctal obstruction                                                   1
  Upper and lower canalicular obstruction                                               1
  Upper and lower punctal obstruction combined with nasolacrimal duct obstruction       1
  Upper and lower canalicular obstruction combined with nasolacrimal duct obstruction   1

Assessment of tear meniscus {#sec008}
---------------------------

Cross-sectional images of the lower tear meniscus were captured vertically across the central cornea using swept-source anterior segment optical coherence tomography (OCT) (SS-1000, CASIA; Tomey Corp, Nagoya, Japan). The OCT images were processed using the in-built software. The principles, technique, and reproducibility of this device for evaluating tear meniscus have been described previously \[[@pone.0233295.ref012],[@pone.0233295.ref013]\]. Lower tear meniscus height (TMH) and lower tear meniscus area (TMA) were calculated from the cross-sectional OCT images of the lower tear meniscus. The measurement was performed between 4 and 5 seconds after blinking, with spontaneous eye-opening.

Assessment of contrast sensitivity {#sec009}
----------------------------------

We measured three indices of contrast sensitivity function: contrast sensitivity (using the CSV-1000E chart), low-contrast VA (using the CSV-1000LanC10% chart), and letter contrast sensitivity (using the CSV-1000LV chart), which were obtained from Vector Vision CO., Greenville, OH, U.S.A. The pupils of the eyes were undilated during these monocular tests, and these tests were performed under photopic conditions. The testing distance was 2.5 m, with the best spectacle correction. The fluorescent luminance source of the instrument, which was automatically calibrated to 85 cd/m^2^, provided background illumination for the translucent chart.

The CSV-1000E chart has vertical sine-wave gratings at four spatial frequencies, i.e., 3, 6, 12, and 18 cycles/degree, and each spatial frequency has eight different levels of contrast. Each row consists of eight pairs of circular patches and includes sine waves of a single spatial frequency. One patch of each pair presents a grating, and the other patch is blank. The patients were asked to identify the patch with the grating, and the contrast level of the last correct response was defined as the contrast threshold in logarithmic values for each frequency \[[@pone.0233295.ref014]\]. The area under the log contrast sensitivity function (AULCSF) was calculated from these data, according to the method described by Applegate et al. \[[@pone.0233295.ref015]\]. The AULCSF was determined as the integration of the fitted third-order polynomials of the log contrast sensitivity units between the fixed limits of 0.48 (corresponding to three cycles/degree) and 1.26 (18 cycles/degree) on the log spatial frequency scale. This presents contrast sensitivity data as one number and makes statistical analysis easier.

The CSV-1000LanC10% chart uses the Landolt ring as the optotype under 10% low-contrast. There are five letters per line, and each one-line step represents a change of 0.1 logMAR units. Low-contrast VA was scored by assigning a value of 0.02 logMAR units for each correctly identified letter.

The CSV-1000LV chart uses letter optotypes. Each letter is of the same size and is of low spatial frequency (2.4 cycles/degree). There are eight contrast levels (standard, 35.5%, 17.8%, 8.9%, 6.3%, 4.5%, 2.2%, and 1.1%), and each contrast level has three letters. The test results were recorded as the number of correctly identified letters and not as the contrast sensitivity or contrast threshold \[[@pone.0233295.ref016],[@pone.0233295.ref017]\].

Statistical analyses {#sec010}
--------------------

Normally distributed data obtained from the affected eyes were compared with the contralateral eyes using the paired t-test (two-tailed test). Data that were not normally distributed were compared using the Wilcoxon signed-rank test. Analysis of the correlation between the difference in tear meniscus dimension (TMH and TMA) and the difference in QoV (BCVA and contrast sensitivity) of the affected and contralateral eyes were evaluated using Pearson correlation coefficient. *P* values \< 0.05 were considered significant for all analyses. Statistical analysis was performed using Statcel (add-in software for Microsoft Excel), version 4 (Microsoft Corp., Redmond, WA).

Results {#sec011}
=======

Comparison of parameters between affected and contralateral eyes {#sec012}
----------------------------------------------------------------

[Table 2](#pone.0233295.t002){ref-type="table"} shows the comparison of the BCVA, AULCSF, low-contrast VA, letter contrast sensitivity, TMH, and TMA for the affected and contralateral eyes. BCVA was comparable for both eyes, while AULCSF was significantly lower in the affected eye when compared to the contralateral eye (*P* = 0.032, Wilcoxon signed-rank test). [Fig 1](#pone.0233295.g001){ref-type="fig"} shows the contrast sensitivity at four specific frequencies for the affected and contralateral eyes. There was a significant difference in contrast sensitivity at 12 cycles/degree (*P* \< 0.005, paired t-test), while there was no significant difference in contrast sensitivity at the other three spatial frequencies.

![Contrast sensitivity at four specific frequencies in the affected and contralateral eyes.\
There was a significant difference in contrast sensitivity at 12 cycles/degree (\*P \< 0.005; paired t-test). Values are expressed as mean ± SD.](pone.0233295.g001){#pone.0233295.g001}

10.1371/journal.pone.0233295.t002

###### Comparison between the measured parameters for the affected and contralateral eyes.

![](pone.0233295.t002){#pone.0233295.t002g}

  Parameters                                                                              Affected Eyes       Contralateral Eyes   *P* Value
  --------------------------------------------------------------------------------------- ------------------- -------------------- -----------
  [^a^](#t002fn001){ref-type="table-fn"}BCVA (logMAR)                                     -0.1 ± 0.05         -0.11 ± 0.06         0.341
  [^b^](#t002fn002){ref-type="table-fn"}AULCSF                                            1.35 (1.22--1.44)   1.36 (1.28--1.46)    0.032
  [^a^](#t002fn001){ref-type="table-fn"}Low-contrast visual acuity (logMAR)               0.18 ± 0.18         0.16 ± 0.04          0.654
  [^a^](#t002fn001){ref-type="table-fn"}Letter contrast sensitivity (number of letters)   23 ± 1.1            22.8 ± 1.3           0.314
  [^a^](#t002fn001){ref-type="table-fn"}Tear meniscus height (mm)                         0.52 ± 0.21         0.33 ± 0.14          \< 0.005
  [^a^](#t002fn001){ref-type="table-fn"}Tear meniscus area (mm^2^)                        0.1 ± 0.09          0.04 ± 0.03          \< 0.005

^a^Data are presented as mean ± SD. *P* value is evaluated using paired t-test.

^b^Data are expressed as median (interquartile range). *P* value is evaluated using Wilcoxon signed-rank test.

BCVA, best-corrected visual acuity; AULCSF, area under the log contrast sensitivity function.

No significant differences were observed in the low-contrast VA (*P* = 0.654, paired t-test) and letter contrast sensitivity (*P* = 0.314, paired t-test) between the affected and contralateral eyes. The lower tear meniscus parameters determined by the TMH and TMA were significantly higher in the affected eye, when compared to the contralateral eye (*P* \< 0.005, paired t-test).

Correlations between the difference in tear meniscus and the difference in quality of vision of affected and contralateral eyes {#sec013}
-------------------------------------------------------------------------------------------------------------------------------

The difference in AULCSF of the affected and contralateral eyes did not correlate with the difference in TMH (r = -0.09, p = 0.491) or TMA (r = 0.04, p = 0.784). The difference in log contrast sensitivity in 12cpd was neither correlated to the difference in TMH (r = 0.01, p = 0.931) and in TMA (r = 0.09, p = 0.502). As for other contrast sensitivity measurements, the difference in Low-contrast visual acuity was not correlated to the difference in TMH (r = 0.09, p = 0.498) and in TMA (r = -0.02, p = 0.862). Letter contrast sensitivity was negatively correlated to TMH (r = -0.26, p = 0.044) but was not correlated to TMA (r = -0.20, p = 0.132). The difference in BCVA was not correlated to the difference in TMH (r = 0.12, p = 0.358) and in TMA (r = 0.07, p = 0.601).

Discussion {#sec014}
==========

To the best of our knowledge, this is the first study to report a reduction in contrast sensitivity in eyes with epiphora caused by unilateral lacrimal passage obstruction. Although there were no significant differences in the conventional BCVA between eyes with epiphora and the contralateral eyes; the contrast sensitivity calculated as AULCSF was significantly decreased in the eyes with lacrimal passage obstruction and epiphora.

Contrast sensitivity, which is related to the deterioration in the quality of vision, is reduced in various ocular diseases, such as cataract \[[@pone.0233295.ref018],[@pone.0233295.ref019]\], glaucoma \[[@pone.0233295.ref020]\], vitreous floaters \[[@pone.0233295.ref021]\], age-related macular degeneration \[[@pone.0233295.ref020],[@pone.0233295.ref022]\], and neuromyelitis optica spectrum disorders \[[@pone.0233295.ref023]\], and also in refractive abnormalities such as LASIK intervention \[[@pone.0233295.ref024],[@pone.0233295.ref025]\], myopia \[[@pone.0233295.ref026]\], and multifocal contact lenses \[[@pone.0233295.ref027],[@pone.0233295.ref028]\]. How well a patient sees at the higher spatial frequency channels, which is well captured by conventional measures of visual acuity, does not necessarily predict vision at middle and lower frequencies \[[@pone.0233295.ref029]\]. For example, increased higher-order aberrations in eyes with LASIK intervention cause deterioration of contrast sensitivity while visual acuity is not affected \[[@pone.0233295.ref025]\]. Contrast sensitivity tests are more sensitive than standard VA testing and should be performed in patients with various tears/corneal abnormalities. Since a decline in VA is rarely detected in patients with epiphora caused by lacrimal passage obstruction, it is crucial to assess contrast sensitivity function to understand the link between the symptoms and their impact on the quality of life. Moreover, activities related to the quality of life, including driving \[[@pone.0233295.ref019],[@pone.0233295.ref030]\], mobility, walking speed \[[@pone.0233295.ref031],[@pone.0233295.ref032]\], reading speed \[[@pone.0233295.ref033],[@pone.0233295.ref034]\], and computer task accuracy \[[@pone.0233295.ref035]\] are reportedly associated with contrast sensitivity. Patients with epiphora often have difficulties in driving, descending stairs, reading books, or text on computer monitors, which might be affected by deterioration of contrast sensitivity.

Deterioration of contrast sensitivity occurs in dry eye disease, a common disease characterized by abnormalities in the tear film on the ocular surface. Koh et al. reported that AULCSF decreased to 1.24 ± 0.16 in patients with dry eye, while that of normal eyes was 1.35 ± 0.11 (the participants' ages were approximately 50 years in both groups) \[[@pone.0233295.ref036]\]. In our study, the AULCSF was 1.35 ± 0.15 in the unaffected eyes, which was comparable with the findings of Koh et al. However, the AULCSF in the affected eyes was 1.32 ± 0.16 in our group and exhibited a significantly lower deterioration compared to that in patients with dry eye in the above-mentioned study.

Contrast sensitivity in high spatial frequencies was affected in epiphora caused by lacrimal passage obstruction. Contrast sensitivity in low spatial frequencies are critical for orientation-mobility performance \[[@pone.0233295.ref037]\] such as walking or stair ascent/descent \[[@pone.0233295.ref038]\]. At the same time, contrast sensitivity in high spatial frequencies is also thought to have an important role for fine scale visual information in word perception \[[@pone.0233295.ref039]\]. So it is reasonable for patients with lacrimal passage obstruction to have difficulties in recognizing traffic signs when driving or reading books with small letters. Contrast sensitivity function in high spatial frequencies tends to worsen with the deterioration of optical quality caused by diseases, such as cataract \[[@pone.0233295.ref040]\], dry eye \[[@pone.0233295.ref041]\], and after refractive surgery \[[@pone.0233295.ref024],[@pone.0233295.ref042]\]. High spatial frequency components of the retinal image significantly deteriorate with optical defocus, while low spatial frequency inputs remain relatively unchanged \[[@pone.0233295.ref043]\].

AULCSF was not correlated with tear meniscus parameters in this study. Similarly, Koh et al. reported that TM parameters were not correlated to quality of vision or optical quality in patients with epiphora due to nasolacrimal passage obstruction \[[@pone.0233295.ref003]\]. We hypothesized that quality of vision, such as contrast sensitivity, is reduced by not only TM over volume but also abnormality of tear film other than volume, such as viscosity or clarity. Hiraoka et al. reported that increased light scattering after instillation of brinzolamide cause deterioration of contrast sensitivity \[[@pone.0233295.ref011]\]. In patients with lacrimal passage obstruction, it is possible that light scattering may increase because of excessive retention of proteins in tear film not excreted to nasal fossa. Although there was no difference in letter contrast sensitivity between affected and contralateral eyes, the difference in letter contrast sensitivity of the affected and contralateral eyes was negatively correlated to the difference in TMH. We need to conduct a further study with a larger sample size to discuss this result.

In this study, there was a significant difference in AULCF between affected and contralateral eye. Furthermore, there were no significant differences seen in either letter contrast sensitivity or in low contrast VA. AULCSF assesses the broad contrast sensitivity function from low to high spatial frequency, while letter contrast sensitivity and low-contrast VA assess the contrast sensitivity function from limited spatial frequency. As a result, AULSCF might be more sensitive than letter contrast sensitivity and low-contrast VA \[[@pone.0233295.ref044]\]. Letter contrast sensitivity and low-contrast VA are simplified methods in clinical use but may not be an appropriate method to evaluate a contrast sensitivity function in patients with lacrimal passage obstruction.

One limitation of this study is that the contralateral eyes were different from the normal eyes. Although we confirmed that the lacrimal passage was intact using the lacrimal passage irrigation test, there might have been subclinical stenosis of lacrimal passage in the contralateral eye. Hence, it was meaningful to compare the parameters of the affected and contralateral eye with paired sample statistical analysis. Various types of lacrimal passage obstruction were included in this study. Future studies with larger sample sizes may analyze contrast sensitivity with each type of obstruction. Also, other ocular surface-related parameters such as blink rate should be assessed in a further study since it could impact visual function measures, including contrast sensitivity function.

In conclusion, contrast sensitivity function underwent a significant decline in eyes with epiphora caused by lacrimal passage obstruction. Thus, contrast sensitivity measurement might aid our understanding of visual disturbances in patients with lacrimal passage obstruction and also serve as one of the decisive parameters for surgical interventions in addition to a risk of dacryocystitis or developing intractable conjunctivitis.

We would like to thank Editage ([www.editage.jp](http://www.editage.jp/)) for English language editing.
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Comment \#2. A major issue in the manuscript relates to the lack of rationale - or at least evidence of the rationale - for undertaking this study. This needs to be addressed within the manuscript Introduction and Abstract. This includes for example, references to support the contention that nasolacrimal obstruction-induced epiphora impacts on visual function (including visual acuity and contrast sensitivity). Do other types of epiphora produce changes in visual function?

\>Response: Thank you for your comments. We have added the following passages and references to the manuscript to provide a more thorough rationale:

Contrast sensitivity is reduced in epiphora induced by conjunctivochalasis (Qiu, W. et al. Evaluation of the Effects of Conjunctivochalasis Excision on Tear Stability and Contrast Sensitivity. Sci. Rep. 2016. 6, 37570) or instillation of a gel-forming solution or particle suspension (Hiraoka T, et al. Contrast Sensitivity and Optical Quality of the Eye after Instillation of Timolol Maleate Gel-Forming Solution and Brinzolamide Ophthalmic Suspension. Ophthalmology 2010. 117:11:2080-2087). As a result, we hypothesize that contrast sensitivity will also be reduced in eyes with epiphora due to lacrimal passage obstruction (lines 47-53).

abstract (line 21):

"Epiphora causes deterioration in contrast sensitivity in some eye diseases. This study was conducted to investigate contrast sensitivity in eyes with epiphora caused by lacrimal passage obstruction."

Comment \#3. Please indicate if any medications (topical or systemic) were used by participants in the study or if this was an exclusion criteria (not mentioned in the Methods). Were participants assessed for any other ocular surface-related parameters apart from lower tear meniscus height and area? Blink rate for example, could impact visual function measures. Can the authors provide details on how long the participants had been diagnosed with epiphora and how long the nasolacrimal obstruction had been present?

\>Response: Patients receiving ophthalmic solution stopped using ophthalmic solution 4 weeks before examinations. We added the description to the methods (lines 68-69).

General ocular surface parameters such as Schirmer\'s test or tear film breakup time are not necessarily suitable because measurement results vary in eyes with epiphora due to lacrimal passage obstruction. Since many studies investigate epiphora in NLDO measures TMH and TMA using OCT (Koh S, et al. The effect of ocular surface regularity on contrast sensitivity and straylight in dry eye. Invest Ophthalmol Vis Sci. 2017;58:2647--265. Qiu W, et al. Evaluation of the Effects of Conjunctivochalasis Excision on Tear Stability and Contrast Sensitivity. Sci. Rep 2016. 6, 37570), we also measured TMH and TMA. As suggested, blink rate could impact visual function measures, but we did not accessed blink rate in this study. We added the possible impact of blink rate to visual function measures in discussion section (line 249).

"Also, other ocular surface-related parameters such as blink rate should be assessed in a further study since it could impact visual function measures, including contrast sensitivity function."

As suggested, We added the description about duration of epiphora in methods (line 81). "The patients presented with epiphora for a median duration of 9 (range 2-82, interquartile range 3-20.5) months."

Comment\#4. The statistical analyses used requires further details including whether normality of results were tested for/ taken into account. Also the choice of tests used is important an (for example, Figure 1 - why use a t-test when an ANOVA is more appropriate?).

\>Response: As suggested, we tested the normality of the result, and some data did not have normal distribution. So we performed Wilcoxon signed-rank test in these date and corrected method (line 130) and result (line 146, 151, 152, table 2). As the reviewer suggested, ANOVA should be appropriate to analyze the difference among group means in a sample. On the other hand, Wilcoxon test for AULCSF, as kind of a group means of several log contrast sensitivity with different cpd, is generally used to compare contrast sensitivity between two groups (Hiraoka T, et al. Contrast Sensitivity and Optical Quality of the Eye after Instillation of Timolol Maleate Gel-Forming Solution and Brinzolamide Ophthalmic Suspension. Ophthalmology 2010. 117:11:2080-2087. Koh S, et al. The effect of ocular surface regu-larity on contrast sensitivity and straylight in dry eye. Invest Ophthalmol Vis Sci. 2017;58:2647--265). In this study, since we found a significant difference in AULCSF. We tried to analyze the difference of log contrast sensitivity for each cpd, so that we can have an idea which cpd is contributable.

Comment\#5. Please provide information for pupil size during contrast sensitivity tests; the authors note pupils were not dilated but nothing on pupil sizes of affected and contralateral eyes.

\>Response: We did not measure pupil size, but the test was performed under photopic condition. (We added the description in method, line 101) Patients with anisocoria were excluded in this study (we added the description in method, line 75).

"The pupils of the eyes were undilated during these monocular tests, and these tests were performed under photopic conditions."

Comment\#6. The Results section does not provide a complete overview of the tests undertaken, as described in the Methods. The contrast sensitivity outcomes for letters and Landolt C are mentioned in Table 1, but not described in any detail (nor in the Discussion). The same goes for the very brief mention of lower lid tear meniscus height and area. These were noted as significantly different between affected and contralateral eyes in Table 1, but briefly noted to be not related to only AULCSF (no mention of letters or Landolt C contrast sensitivity).

\>Response: We added the p-value of the contrast sensitivity outcomes for letters and Landolt C in the results (line 151, 152) and discussed the differences between three contrast sensitivity measurements in the discussion (line 232).

"In this study, there was a significant difference in AULCF between affected and contralateral eye. Furthermore, there were no significant differences seen in either letter contrast sensitivity or in low contrast VA. AULCSF assesses the broad contrast sensitivity function from low to high spatial frequency, while letter contrast sensitivity and low-contrast VA assess the contrast sensitivity function from limited spatial frequency. As a result, AULSCF might be more sensitive than letter contrast sensitivity and low-contrast VA (Parede TRR, et al. Quality of vision in refractive and cataract surgery, indirect measurers: review article. Arq Bras Oftalmol. 2013;76(6):386-90). Letter contrast sensitivity and low-contrast VA are simplified methods in clinical use, but may not be an appropriate method to evaluate a contrast sensitivity function in patients with lacrimal passage obstruction."

We added the description about correlation between tear meniscus parameters and letters or Landolt C contrast sensitivity in the result (line 170).

"Although there was no difference in letter contrast sensitivity between affected and contralateral eyes, the difference in letter contrast sensitivity of the affected and contralateral eyes was negatively correlated to the difference in TMH. We need to conduct a further study with larger sample size to discuss this result." (line 228)

Comment\#7. The underlying mechanism for the reduced contrast sensitivity is not clearly explored in the Discussion, and this would enhance the impact of the findings.

\>Response:

AULCSF was not correlated with TM parameters. So we hypothesized that contrast sensitivity is reduced by not only TM over volume but also abnormality of tear film other than volume, such as viscosity or clarity. Hiraoka et al. report that increased light scattering after instillation of brinzolamide cause deterioration of contrast sensitivity (Hiraoka T, et al. Contrast Sensitivity and Optical Quality of the Eye after Instillation of Timolol Maleate Gel-Forming Solution and Brinzolamide Ophthalmic Suspension. Ophthalmology 2010. 117:11:2080-2087). In patients with lacrimal passage obstruction, it is possible that light scattering may increase because of excessive retention of proteins in tear film not excreted to nasal fossa. We added this in the discussion section (line 222).

Comment\#8. The authors state in the conclusion (p. 14) that contrast sensitivity reduction may serve as a \'decisive parameter for surgical interventions\'. Can the authors please include here (briefly) other critical (acute) factors taken into account in these cases where surgery is advised?

\>Response: Surgery is also considered when patients are at risk of dacryocystitis or developing intractable conjunctivitis. We added the description to the discussion (line 256).

Reviewer \#1

Comment \#1: This is interesting study focused on the influence of epiphora due to lacrimal passage obstruction on basic visual functions. The manuscript (all the parts: introduction, method, results and disccusion) is rather short and focused on the topic indicated in the title what makes it clear. However some elements should be changed, expanded:

\>Response:

Thank you for your comments. Folloing your instructions, I have changed and expanded some elements in the manuscript.

Comment\#2:

Introduction:

line 51: \"We hypothesized that epiphora caused by lacrimal passage obstruction might affect contrast sensitivity\" but why? what is the reason? what mechamism could be responsible for that?

\>Response:

We have added expanded on the rationale and hypothesis of the study.

Contrast sensitivity is reduced in epiphora induced by conjunctivochalasis (Qiu, W. et al. Evaluation of the Effects of Conjunctivochalasis Excision on Tear Stability and Contrast Sensitivity. Sci. Rep. 2016. 6, 37570) or instillation of a gel-forming solution or particle suspension (Hiraoka T, et al. Contrast Sensitivity and Optical Quality of the Eye after Instillation of Timolol Maleate Gel-Forming Solution and Brinzolamide Ophthalmic Suspension. Ophthalmology 2010. 117:11:2080-2087). As a result, we hypothesize that contrast sensitivity will also be reduced in eyes with epiphora due to lacrimal passage obstruction (lines 47-53).

abstract (line 21):

"Epiphora causes deterioration in contrast sensitivity in some eye diseases. This study was conducted to investigate contrast sensitivity in eyes with epiphora caused by lacrimal passage obstruction."

Materials and methods:

line 64: indicate that VA of 20/20 or better on both eyes

\>Response: Thank you for your review. We added "in both eyes" in after "VA of 20/20 or better".

line 71: word ALSO should be added before EXCLUDED

\>Response: We added "also" before "excluded".

line 122-127: why Spearman\'s rank correlation was used but not Pearson correlation? No information about normality of data distribution is included. When t-test was used this suggests that data had normal distribution, so why Spearman test was used? Spearman test is unparametric test, so maybe some data had un-normal distribution? If some data had un-normal distribution is should be noted and not only mean but also median values should be presented in

the table 2. Please explain this point.

\>Response: Thank you for your careful review. It was our mistake to describe Spearman's rank correlation. We actually used Pearson correlation coefficient, and revised the method (line 135). Some of our data had un-normal distribution, so we also revised methods (line 130) and the result (line 146, 148, 151, table2) to clarify this.

Results:

The description of the results is rather poor. In the lines 136-137 statistical data should be added (p-val). Line 142-145- this part is rather strange. Heading has two lines and the text only two lines. More data should be presented (figures, statistics, even if insignificant). Moreover, correlation between TMH and TMA with 12 c/deg CS should also be performed and presented.

Part in line 146-151 should not be described as a separate result part but should be included in the earlier section where AULCSF was presented, since it describe CSF but in different way different/additional analysis. Additionally, why t-test was used when comparing different spatial frequencies? Anova with repeated measurements should be used together with posthoc tests, but not separate t-tests in this analyses.

\>Response:

Following your instructions, we added p-values in results.

As suggested, we have added more detail in the last part of result section.

We changed the title of this part as follows: Correlations between the difference in tear meniscus and the difference in quality of vision of affected and contralateral eyes

As suggested, we checked the correlation between TMH and TMA with 12 cpd CS, and found no correlation (line169).

Also, following the editor\'s suggestion, we added the results of the correlation between TMH and TMA with other contrast sensitivity measurements and BCVA (line 170).

As suggested, a paragraph describing contrast sensitivity at four specific frequencies for the affected and contralateral eyes has been moved in the earlier section where AULCSF was presented (line 147).

As suggested, ANOVA should be appropriate to analyze the difference among group means in a sample. On the other hand, Wilcoxon test for AULCSF, as kind of a group means of several log contrast sensitivity with different cpd, is generally used to compare contrast sensitivity between two groups \[Hiraoka T, et al. Contrast Sensitivity and Optical Quality of the Eye after Instillation of Timolol Maleate Gel-Forming Solution and Brinzolamide Ophthalmic Suspension. Ophthalmology 2010. 117:11:2080-2087. Koh\]. In this study, since we found a significant difference in AULCSF. We also attempted to analyze the difference of log contrast sensitivity for each cpd, to gain insight into which cpd contributes to this difference.

Discussion:

In general, there is a lack of discussion about insignificant correlation between CS and tear meniscus. If CS reduction is related to the unstable tears film, some correlation should be expected. If not, why? It should be discussed here.

\>Response:

As the reviewer indicated, we added a description to discuss the insignificant correlation between CS and tear meniscus. (line 222)

"We hypothesized that quality of vision, such as contrast sensitivity, is reduced by not only TM over volume but also abnormality of tear film other than volume, such as viscosity or clarity. Hiraoka et al. reported that increased light scattering after instillation of brinzolamide cause deterioration of contrast sensitivity \[35\]. In patients with lacrimal passage obstruction, it is possible that light scattering may increase because of excessive retention of proteins in tear film not excreted to nasal fossa."

More discussion should be done on the role of high spatial freq. on the every day activities since many motor activities are based on the low (peripheral vision), but not high spatial freq. This topic should be discussed more, on the base of literature.

　Authors should highlight more the important role of CS test in detection of visual disturbances. This test is more sensitive than VA and should be done in patients with various tears/corneal abnormalities to detected real visual problem from others not visual symptoms.

\>Response: Following your advice, we added the description in the discussion. Contrast sensitivity in high spatial frequencies is thought to have an important role for fine-scale visual information in word perception (Geoffrey R, et al. Spatial Frequency Sensitivity Differences between Adults of Good and Poor Reading Ability. Invest Ophthalmol Vis Sci. 2005;46:2219 --2224). As a result, it is reasonable for patients with lacrimal passage obstruction to have difficulties in recognizing traffic sign when driving or reading books with small letters. (line 213)

Contrast sensitivity in low spatial frequencies is critical for orientation-mobility performance \[Marron JA, et al. Visual factors and orientation-mobility performance. Am J Optom Physiol Opt. 1982;59:413-426\] such as walking or stair ascent/descent \[West et al. Arch Ophthalmol 2002;120:774-780\]. We added this in the discussion section (line 213).

As suggested, we added description about the importance of CS in detection of visual desturbances. (line 188)

line 163: change QUALITY OF LIFE into the QUALITY OF VISION

Authours' response: we changed quality of life into the quality of vision (line 185)

lines 164-166: CS is reduced in many ocular abnormalities but also after LASIK intervention (example reference: Influence of Pupil Diameter on the Relation between Ocular Higher-Order Aberration and Contrast Sensitivity after Laser In Situ Keratomileusis, Oshika et al. Investigative Ophthalmology & Visual Science, April 2006, Vol. 47, No. 4) in myopia (The Effect of Myopia on Contrast Thresholds. Bistra D. Stoimenova, Investigative Ophthalmology & Visual Science, May 2007, Vol. 48, No. 5) or with multifocal contact lenses (Katarzyna Przekoracka, et al., Contact Lens and Anterior Eye, <https://doi.org/10.1016/j.clae.2019.12.002;> Visual performance with simultaneous vision multifocal contact lenses, Almudena Llorente-Guillemot et. al., Clin Exp Optom 2012; 95: 1: 54--59).

\>Response: Following your advice, we added the sentences in the discussion section (line 187) and references.

Reviewer \#2: Reviewer's comments:

The study investigated the effect of epiphora on contrast sensitivity. This is an important study with case series that showed the association decrease in contrast sensitivity with epiphora. The authors have described this study clearly in their paper and it was thus easy to follow.

There are a couple of comments which will help to enhance the impact of the paper:

Comment 1: Line 91- 92: Please correct the typo error of repeated word: 'were obtained'.

\>Response:

Thank you for your comments. Following your instructions, I have corrected the typo error of repeated word: 'were obtained'. (line 100)

Comment 2: The introduction is very succinct and easy to follow. However, with regards to epiphora leading to decrease in QoV and quality of life, it would be good if the authors could provide the data (actual numbers) from the literature that has been referenced so that the readers can gauge the ballpark of quality of life and vision that epiphora will affect.

E.g., line 45: If vision-related quality of life was significantly impaired before silicon tube intubation, then what was the actual number before and after the procedure.

\>Response:

Composite score from the 25-item national eye institute visual function questionnaire（NEIVFQ-25）improved 76.3 ± 11.5 to 82.0 ± 11.3, p=0.001. We added the description in the introduction section. (line 48)

Comment 3: When the affected and contralateral eyes were compared, there was a significant difference in AULCF while there were no significant differences seen in either low contrast visual acuity or in letter contrast sensitivity. It will be good to discuss the differences between these three methods in the discussion. It will also enhance the paper by highlighting how this can be done in a clinical setting.

\>Response:

We added this content to the discussion section (line 237).

AULCSF assesses the broad contrast sensitivity function from low to high spatial frequency, while letter contrast sensitivity and low-contrast VA assess the contrast sensitivity function from limited spatial frequency. As a result, AULSCF might be more sensitive than letter contrast sensitivity and low-contrast VA (Parede TRR, Torricelli AMM, Mukai A, Netto MV, Bechara SJ, Quality of vision in refractive and cataract surgery, indirect measurers: review article. Arq Bras Oftalmol. 2013;76(6):386-90). Letter contrast sensitivity and low-contrast VA are simplified methods in clinical use but may not be an appropriate method to evaluate a contrast sensitivity function in patients with lacrimal passage obstruction.
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1\. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the "Comments to the Author" section, enter your conflict of interest statement in the "Confidential to Editor" section, and submit your \"Accept\" recommendation.

Reviewer \#1: (No Response)

Reviewer \#2: All comments have been addressed
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2\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

3\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Have the authors made all data underlying the findings in their manuscript fully available?
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5\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.
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No more comments.
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